AI drug discovery comes of age
Bringing a new drug to the clinic is a tortuous and extremely expensive process fraught with commercial risk. It seems that Artificial...
Edit Profile
Dr Daniel Rowe
Senior Associate at Dehns
Oxford, United Kingdom
- +44 (0)20 7632 7200
- drowe@dehns.com
- http://www.dehns.com/
About Me
Daniel Rowe graduated from the University of Bristol with a First Class Honours Degree in Biochemistry. He has since been awarded a PhD by the University of Bristol for his research into the intracellular mechanisms underlying vein graft failure. He has the Certificate in Intellectual Property Law from Queen Mary College, University of London.
Dr Daniel Rowe's Passles
Inspired thinking – providing fresh insight to the world of IP
Most Read
Double patenting at the EPO – the Enlarged Board takes a second look
The EPO’s practice on double patenting has been rather settled over the past decade. As indicated in the EPO’s Guidelines for...
What price biotech innovation?
A recent landmark decision of the Court of Justice of the European Union (CJEU) on the use of gene editing technologies to create new...
Life Sciences Patent Network Meeting, Boston 26 April 2018 – a report from the cutting edge
Yesterday I attended LSPN’s spring North America meeting, and what a stimulating and valuable event it was. Gathered together was a...
CRISPR patent pool moves closer
As reported earlier, signs that a CRISPR patent pool could be on the horizon have been appearing over the past few months. The Broad...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net
-
Search site
-
Contact our offices